A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report.


Journal

Birth defects research
ISSN: 2472-1727
Titre abrégé: Birth Defects Res
Pays: United States
ID NLM: 101701004

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 12 04 2019
revised: 27 06 2019
accepted: 12 07 2019
pubmed: 25 7 2019
medline: 31 7 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

Clinical studies on the effects of thalidomide-induced damage on thalidomide victims as they age have only recently started to be conducted, but no studies have examined socioeconomic differences in terms of healthcare and social status between thalidomiders and the age-matched general population in Japan. Therefore, we carried out a nationwide survey focusing on the life situations of thalidomiders. Questionnaires were sent to 274 thalidomiders in Japan. The questionnaire items basically matched those of the Comprehensive Survey of Living Conditions (CSLC) in the general population conducted by the Japanese Government. The results were compared with those of the CSLC for individuals aged 55-59 years, which was the cohort most similar in age to the average thalidomider living in Japan. More thalidomiders rated their health condition as relatively bad or bad compared with the general population (20.2% vs. 13.3%, respectively). A much higher percentage of thalidomiders reported having some health or physical problem caused by a disease or injury (68.8% vs. 32.6%, respectively), and thalidomiders reported visiting medical and healthcare-related facilities more frequently. A higher proportion of thalidomiders (9.2%) were unemployed, and thalidomiders tended to feel higher levels of worry and stress, especially in terms of the future. The results of this nationwide survey of the life situations of thalidomiders in Japan clarified their health conditions and the related associations with socioeconomic status. These findings could be expected to help improve the provision of medical and healthcare, welfare measures, and financial support for thalidomiders in the near future.

Sections du résumé

BACKGROUND
Clinical studies on the effects of thalidomide-induced damage on thalidomide victims as they age have only recently started to be conducted, but no studies have examined socioeconomic differences in terms of healthcare and social status between thalidomiders and the age-matched general population in Japan. Therefore, we carried out a nationwide survey focusing on the life situations of thalidomiders.
METHOD
Questionnaires were sent to 274 thalidomiders in Japan. The questionnaire items basically matched those of the Comprehensive Survey of Living Conditions (CSLC) in the general population conducted by the Japanese Government. The results were compared with those of the CSLC for individuals aged 55-59 years, which was the cohort most similar in age to the average thalidomider living in Japan.
RESULTS
More thalidomiders rated their health condition as relatively bad or bad compared with the general population (20.2% vs. 13.3%, respectively). A much higher percentage of thalidomiders reported having some health or physical problem caused by a disease or injury (68.8% vs. 32.6%, respectively), and thalidomiders reported visiting medical and healthcare-related facilities more frequently. A higher proportion of thalidomiders (9.2%) were unemployed, and thalidomiders tended to feel higher levels of worry and stress, especially in terms of the future.
CONCLUSIONS
The results of this nationwide survey of the life situations of thalidomiders in Japan clarified their health conditions and the related associations with socioeconomic status. These findings could be expected to help improve the provision of medical and healthcare, welfare measures, and financial support for thalidomiders in the near future.

Identifiants

pubmed: 31339667
doi: 10.1002/bdr2.1558
pmc: PMC7432171
doi:

Substances chimiques

Thalidomide 4Z8R6ORS6L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1633-1642

Informations de copyright

© 2019 The Authors. Birth Defects Research published by Wiley Periodicals, Inc.

Références

Birth Defects Res A Clin Mol Teratol. 2015 Sep;103(9):787-93
pubmed: 26033770
Disabil Health J. 2018 Apr;11(2):184-191
pubmed: 29109034
Birth Defects Res. 2019 Dec 1;111(20):1633-1642
pubmed: 31339667
PLoS One. 2017 Oct 20;12(10):e0186388
pubmed: 29053750
Clin Radiol. 2016 Nov;71(11):1199.e1-7
pubmed: 27567725
Circ J. 2018 Aug 24;82(9):2364-2371
pubmed: 29998932
PLoS One. 2016 Apr 21;11(4):e0152902
pubmed: 27100829
Birth Defects Res A Clin Mol Teratol. 2015 Sep;103(9):794-803
pubmed: 26043318
PLoS One. 2016 May 13;11(5):e0155493
pubmed: 27175919
J Child Orthop. 2016 Dec;10(6):691-703
pubmed: 27854003
J Child Orthop. 2014 Oct;8(5):423-33
pubmed: 25301261
PLoS One. 2019 Jan 16;14(1):e0210222
pubmed: 30650111
Psychiatry Clin Neurosci. 2014 Jun;68(6):479-86
pubmed: 24548169

Auteurs

Fumihiko Hinoshita (F)

Department of Nephrology, National Center for Global Health and Medicine, Tokyo, Japan.

Hiroko Beppu (H)

Department of Nephrology, National Center for Global Health and Medicine, Tokyo, Japan.

Shingo Shioji (S)

Department of Nephrology, National Center for Global Health and Medicine, Tokyo, Japan.

Junko Fujitani (J)

Department of Rehabilitation, National Center for Global Health and Medicine, Tokyo, Japan.

Koubun Imai (K)

Department of Psychiatry, National Center for Global Health and Medicine, Tokyo, Japan.

Tsuyoshi Tajima (T)

Department of Radiology, National Center for Global Health and Medicine, Tokyo, Japan.

Tetsuya Tagami (T)

Center for Health Examination, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Shin Ohnishi (S)

Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH